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Toxoplasma infection in gastrointestinal (GI) tract is rare, and occurs
in the setting of disseminated infectionwhere it occurs in 6 to 20% of pa-
tients [1–3]. Any or all gastrointestinal sites may be involved. Patients
most commonly complain of abdominal pain, but diarrhea, nausea,
vomiting and anorexia may also occur [4,5]. Toxoplasmosis of the GI
tract in patients after allogeneic hematopoietic stem cell transplanta-
tion, although rare, can be very difﬁcult to differentiate from graft-
versus-host disease (GVHD) and misdiagnosis can have a major impact
on patient's outcome, considering different treatment modalities. Here
we report a case of duodenal toxoplasmosis following allogeneic stem
cell transplant.2. Report of a case
Our patient was a 48 year-old Caucasian female with a history of
myelodysplastic syndrome (MDS), who underwent matched allogeneic
stem cell transplant. Onemonth later, she presentedwith fever, abdom-
inal pain, vomiting and diarrhea. Her physical examination was within
normal limits. Laboratory studies revealed pancytopenia and mild ele-
vation of glucose and creatinine. All blood and urine bacterial, viral
and fungal cultures were negative. No cytomegalovirus (CMV) viremia
was detectable by polymerase chain reaction (PCR). However, she had
Epstein Barr virus (EBV) reactivation with 10,750 copies/ml of the
virus in whole blood, which she was treated with a dose of rituximab.
A clinical suspicion of GVHD versus infection was raised. Endoscopic
biopsy of the duodenum demonstrated extensive apoptotic bodies,
crypt necrosis and focal mucosal denudation, consistent with severe
acute GI-GVHD grade 4 of 4. Rectal biopsy also showed increased apo-
ptosis, crypt abscesses and focal crypt necrosis, consistent with GVHD
grades 2–3 of 4. The patient was managed by increasing the dosage ofsirolimus, Mycophenolate Mofetil (MMF), and initiation of tacrolimus
and high dose prednisone. However, her symptoms persisted and she
had recrudescence of fever accompanied by multiple episodes of diar-
rhea and melena. The patient was readmitted and repeated endoscopic
biopsies of duodenum revealed duodenal toxoplasmosis. Concurrent
blood PCR however was negative for the organism. Immediately, her
treatment regimen was changed and anti-toxoplasmosis drugs were
initiated which she had partial response to it.
On hospital day 32, she developed respiratory distress. Chest X-ray
demonstrated increased opaciﬁcation of the right hemithorax, likely re-
lated to combination of atelectasis and effusion. Despite all therapeutic
efforts, she continued to deteriorate and unfortunately she died of mul-
tisystem organ failure. A complete autopsy was offered, however the
family declined it.3. Pathologic ﬁndings
Multiple areas of duodenal mucosa were biopsied and showed
marked edema of the lamina propria; mild inﬂammation; focal necrosis
and ulceration; and widespread involvement of mucosa by bradyzoites
of Toxoplasma. They were spindle-shaped intracellular structures with
large nucleoli found within cystic spaces in clusters resembling a
bunch of bananas (Fig. 1, A and B). The number of organisms seen in
lightmicroscopy varied in different tissue fragments and theywere pre-
dominant in the areas with ulcerated mucosa, easily identiﬁable in
hematoxylin–eosin (H&E) stain. True cysts, positive with periodic
acid–Schiff (PAS) stain (Fig. 2), were identiﬁed; however no free
tachyzoite was present.
No viral inclusions were identiﬁed in H&E sections. Special stains
Giemsa (Fig. 3), trichrome, and PAS, performedwith adequate controls,
conﬁrmed the presence of the microorganisms. Acid-fast special stain
was negative.
Fig. 1. A. Spindle-shaped intracellular structureswithin cystic spaces (40x). B. Highermagni-
ﬁcation (60x), showing the microorganisms in clusters, resembling a bunch of bananas.
Fig. 3.Giemsa stain demonstrating the presence ofmicroorganismswithin the cysts (40x).
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Opportunistic infections in general are continued to be life threaten-
ing in patients after allogeneic bone marrow transplantation (BMT) [6].Fig. 2. PAS stain highlighting the cysts (40x).
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geneic BMT [7]. Other studies reported its incidence as 0.31 cases per
100 allogeneic transplants and 1.0 per 100 autopsies [8]. Currently, the
pathogenesis of the Toxoplasma is incompletely understood. It is be-
lieved that the “rapidly multiplying tachyzoites ﬁll up the infected cell,
forming a “pseudocyst” that will eventually rupture and then actively
penetrate the nearby cells. After the host's initial immune response,
the tachyzoites are either destroyed or transform in the encysted form
into dormant, essentially harmless bradyzoites. Cyst formation takes
place in multiple organs, primarily brain, skeletal, and heart muscle
and eyes. The cysts are believed to be responsible for residual (chronic
or latent) infection” [9].
Post BMT toxoplasmosis appears to occur by reactivation of latent
disease secondary to impaired cellular and humoral immunity within
the ﬁrst 6 months post-transplantation, and it usually develops in pa-
tients who were seropositive for the organism pre-transplant. Majority
of the reported cases were disseminated toxoplasmosis that had oc-
curred in patients who were further immunosuppressed with GVHD
and its related treatment. Apparently, matched, unrelated donor-BMT
recipients were more prone to serious infections, partly due to the
higher incidence of GVHD, its prophylactic therapy, and delayed im-
mune reconstitution.Moreover, matched, unrelated donors are not rou-
tinely screened for their toxoplasma serologic status, which may bring
up the possibility of transplant-related transmission [10,11].
There are potential pitfalls in differentiating GI infections from
GVHD, both clinically and pathologically due to the lack of speciﬁc
symptoms and endoscopic ﬁndings. Diarrhea is the most common, but
nonspeciﬁc, presenting symptom in acute GI-GVHD, which can be
seen in infections too. The distinction is difﬁcult especially when there
are no or only limited GVHD related skin lesions [12]. Histological pre-
sentations of the two can also be overlapping and sometimes a subtle
infection can be overlooked on biopsy when the suspicious index is
low. In our case, the patient ﬁrst diagnosed with acute GI-GVHD, how-
ever a month later she readmitted due to fever relapse accompanied
by multiple episodes of diarrhea and melena. She was severely immu-
nocompromised due to immunosuppressant medications and repeated
duodenal biopsies revealed toxoplasmosis. Prior biopsies were
reviewed; and there was no apparent toxoplasmosis at that time on
the reviewed materials. Therefore, we concluded that this was a case
of concurrent GVHD and toxoplasmosis.
Other parasitic infection of the small intestine that can histologically
mimic Toxoplasma and should be considered as part of the differential
diagnosis includes Isospora and Cyclospora. They classiﬁed underbonemarrow transplant patient: A rare case report, Human Path Case
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that infect the intestinal tracts and cause diarrhea in both immunocom-
promised and immunocompetent patients [13]. They can be differenti-
ated from Toxoplasma based on their size criteria, morphological
characteristic and Acid-fast special stain (positive in both Isospora and
Cyclospora and negative in Toxoplasma). The enzyme-linked immuno-
sorbent assay (ELISA) and PCR are available but not widely used.
To date, approximately 60 cases of disseminated toxoplasmosis fol-
lowing BMT have been reported in the literature [8]. In most cases, the
diagnosis was made only after autopsy, and the most frequently in-
volved organs were the brain, lungs, and heart. However, the GI mani-
festation of toxoplasmosis in general and duodenal involvement in
particular, is exceedingly rare [14–16]. To our knowledge, no cases of
isolated duodenal toxoplasmosis in a post BMT patient have been re-
ported in the English literature. Interestingly, in our case concurrent
blood PCR was negative for the organism, which may be due to the iso-
lated nature of the disease.
5. Conclusion
It is very important for both the clinician and the pathologist to
maintain a high index of suspicion for infections (including Toxoplas-
ma) in all post bone marrow transplant patients who have clinical sus-
picious of GI-GVHD. Early diagnosis and treatment reduces the risk of
death associated with localized and disseminated disease.
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